|
2014
|
Invention
|
Inhibitors of lrrk2 kinase activity.
The present invention provides compounds having a structure... |
|
2012
|
Invention
|
Composition for topical treatment of mixed vaginal infections.
A pharmaceutical composition comp... |
|
2011
|
Invention
|
Parkin substrate and assay.
The invention provides in vitro, ex vivo, and in vivo assays for Par... |
|
|
Invention
|
Nanoparticulate cinacalcet formulations. The invention is directed to compositions comprising sta... |
|
|
Invention
|
Prevention and treatment of amyloidogenic diseases.
Passive immunotherapy methods for treating a... |
|
2010
|
Invention
|
Nanoparticulate and controlled release compositions comprising cyclosporine.
The present inventi... |
|
|
Invention
|
Nanoparticulate anticancer compositions and methods for making the same. Described are injectable... |
|
|
Invention
|
Controlled-release clozapine compositions.
A composition for delivery of a drug is disclosed. Th... |
|
|
Invention
|
Alpha-synuclein kinase. The invention provides agents and methods for treatment of diseases assoc... |
|
|
Invention
|
Inhibitors of jun n-terminal kinase. The present disclosure provides inhibitors of c-Jun N-termin... |
|
2009
|
Invention
|
Sustained release aminopyridine composition.
A pharmaceutical composition which comprises a ther... |
|
|
Invention
|
Methods of treatment of hyperuricemia and associated disease states. The invention relates to com... |
|
|
Invention
|
Combination of a triptan and an nsaid. A composition of a triptan and particles of a NSAID. The N... |
|
|
Invention
|
Combination of a triptan and an nsaid. A composition of a triptan and particles of a NSAID... |
|
|
Invention
|
Prevention and treatment of amyloidogenic diseases.
Disclosed are pharmaceutical compositions an... |
|
|
Invention
|
Fenofibrate dosage forms. Disclosed are redispersible fibrate, such as fenofϊbrate, dosage forms.... |
|
|
Invention
|
Compositions for site-specific delivery of imatinib and methods of use.
The invention provides a... |
|
|
Invention
|
Compositions for site-specific delivery of imatinib and methods of use. The invention provi... |
|
|
Invention
|
Compositions for site-specific delivery of imatinib and methods of use. The invention provides an... |
|
|
Invention
|
Prevention and treatment of amyloidogenic disease.
Disclosed are pharmaceutical compositions and... |
|
|
Invention
|
Nanoparticulate compositions of angiogenesis inhibitors. Nanoparticulate compositions comprising ... |
|
|
Invention
|
Nanoparticulate compositions of angiogenesis inhibitors. Nanoparticulate compositions compr... |
|
|
Invention
|
Stable liquid formulations of anti-infective agents and adjusted anti-infective agent dosing regi... |
|
|
Invention
|
Alpha-synuclein kinase. Agents and methods for treatment of diseases associated with Lewy b... |
|
|
Invention
|
Alpha-synuclein kinase. Agents and methods for treatment of diseases associated with Lewy body di... |
|
|
Invention
|
Thermal denaturation screening assay to identify candidate compounds for prevention and treatment... |
|
2008
|
Invention
|
Nanoparticulate anidulafungin compositions and methods for making the same. Nanoparticulate compo... |
|
|
Invention
|
Nanoparticulate anidulafungin compositions and methods for making the same.
Nanoparticulate comp... |
|
|
Invention
|
Dosing regimen.
Methods and kits are provided enabling a twice daily dosing regimen that achieve... |
|
|
Invention
|
Dosing regimen. Methods and kits are provided enabling a twice daily dosing regimen that achieves... |
|
|
Invention
|
Assay for parkinson's disease therapeutics. The invention provides to assays for agent useful for... |
|
|
Invention
|
Parkin substrate and assay. The invention provides in vitro, ex vivo, and in vivo assays for Park... |
|
|
Invention
|
Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
A multi... |
|
|
Invention
|
Gamma radiation sterilized nanoparticulate docetaxel compositions and methods for making the same... |
|
|
Invention
|
Alpha-synuclein kinase.
The invention provides agents and methods for treatment of diseases asso... |
|
2007
|
Invention
|
Nanoparticulate formulations of modafinil.
The present invention is directed to compositions com... |
|
|
Invention
|
Treatment of amyloidogenic diseases. The invention provides preferred dosage ranges, maximum conc... |
|
2006
|
Invention
|
Modified release ticlopidine compositions.
The invention relates to a multiparticulate modified ... |
|
|
Invention
|
Modified release famciclovir compositions.
The invention relates to a multiparticulate modified ... |
|
|
Invention
|
Nanoparticulate and controlled release compositions comprising a platelet aggregation inhibitor. ... |
|
|
Invention
|
Nanoparticulate and controlled release compositions comprising a cephalosporin.
The present inve... |
|
|
Invention
|
Nanoparticulate and controlled release compositions comprising vitamin k2.
The present invention... |
|
|
Invention
|
Controlled release compositions comprising an antipsychotic agent.
The invention relates to a fo... |
|
2003
|
P/S
|
Pharmaceutical preparations. |
